Company profile
Abiologics company profile
Abiologics develops programmable therapeutics using a proprietary platform that combines generative artificial intelligence with high-throughput chemical protein synthesis. The company focuses on creating Synteins™, a new category of supranatural biologics engineered from non-natural building blocks such as D-amino acids. These molecules are designed to address the structural and functional limitations of conventional biologics by enhancing protease resistance, reducing immunogenicity, and improving tissue accessibility.
Business identity
- Website
- https://www.abiologics.com
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
Headquarters
- Headquarters
- Primghar, Iowa, United States
- Country code
- US
- Continent
- North America